Legal Representation
Attorney
Eric D. Cohen
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 12, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 12, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 5, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 4, 2011 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 18, 2011 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 4, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 18, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 15, 2011 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | Loading... |
| Feb 10, 2011 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 10, 2011 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 10, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 10, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 8, 2010 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 8, 2010 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 8, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 29, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 29, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 29, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 16, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 16, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 16, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 10, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 18, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 29, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 16, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 16, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 2, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 2, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 2, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 2, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 2, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 29, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 29, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 29, 2008 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 7, 2008 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 7, 2008 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 7, 2008 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 5, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 4, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 4, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 5, 2007 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 5, 2007 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 5, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 13, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 12, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 12, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 19, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 19, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 18, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 18, 2006 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Detailed Classifications
Class 001
chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anestesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042